Using the theory of planned behavior to examine pharmacists' intention to utilize a prescription drug monitoring program database

Research in Social and Administrative Pharmacy

Volumn 10, Issue 2, 2014, Pages 285-296

  Fleming, Marc L ^a   Barner, Jamie C ^b   Brown, Carolyn M ^b   Shepherd, Marvin D ^b   Strassels, Scott ^b   Novak, Suzanne ^b  

^a UNIVERSITY OF HOUSTON   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Community pharmacists; Diversion; Intention; Prescription drug monitoring program; Theory of planned behavior

Indexed keywords

CONTROLLED SUBSTANCE;

ADULT; ARTICLE; BEHAVIOR; COMMUNITY PHARMACISTS; DIVERSION; DRUG UTILIZATION; FACTUAL DATABASE; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; INFORMATION PROCESSING; MALE; MIDDLE AGED; PHARMACIST; PHARMACY; PRESCRIPTION DRUG MONITORING PROGRAM; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; THEORY OF PLANNED BEHAVIOR; UNITED STATES;

COMMUNITY PHARMACISTS; DIVERSION; INTENTION; PRESCRIPTION DRUG MONITORING PROGRAM; THEORY OF PLANNED BEHAVIOR;

ADULT; ATTITUDE OF HEALTH PERSONNEL; BEHAVIOR; COMMUNITY PHARMACY SERVICES; CONTROLLED SUBSTANCES; DATABASES, FACTUAL; DRUG UTILIZATION; FEMALE; FOCUS GROUPS; HUMANS; INTENTION; MALE; MIDDLE AGED; PHARMACISTS; QUESTIONNAIRES; TEXAS;

EID: 84896714851     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2013.05.009     Document Type: Article

References (55)

1. Office of National Drug Control Policy Epidemic: Responding to America's Prescription Drug Abuse Crisis 2011, Available at:, Accessed 08.12.11. http://www.whitehouse.gov/sites/default/files/ondcp/policy-and-research/rx_abuse_plan.pdf.
2. Paulozzi L.J., Weisler R.H., Patkar A.A. A national epidemic of unintentional prescription opioid overdose deaths: how physicians can help control it. JClin Psychiatry 2011, 72:589-592.
3. Substance Abuse and Mental Health Services Administration Results From the 2010 National Survey on Drug Use and Health: Summary of National Findings: NSDUH Series H-41, HHS Publication No. SMA 11-4658 2011, Office of Applied Studies, Rockville, MD, Available at:, Accessed 05.08.12. http://www.samhsa.gov/data/NSDUH/2k10NSDUH/2k10Results.htm#1.1.
4. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality The DAWN Report: Highlights of the 2010 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits 2012, Available at:, Accessed 04.08.12. http://www.samhsa.gov/data/2k12/DAWN096/SR096EDHighlights2010.htm.
5. Simoni-Wastila L., Tompkins C. Balancing diversion control and medical necessity: the case of prescription drugs with abuse potential. Subst Use Misuse 2001, 36:1275-1296.
6. Volkow N.D., McLellan T.A. Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment. JAMA 2011, 305:1346-1347.
7. Blumenschein K., Fink J.L., Freeman P.R., et al. Review of Prescription Drug Monitoring Programs in the United States 2010, Available at:, Accessed 03.05.11. http://chfs.ky.gov/NR/rdonlyres/85989824-1030-4AA6-91E1-7F9E3EF68827/0/KASPEREvaluationPDMPStatusFinalReport6242010.pdf.
8. United States General Accounting Office Prescription Drugs State Monitoring Programs Provide Useful Tool to Reduce Diversion 2002, Available at:, Accessed 10.08.10. http://purl.access.gpo.gov/GPO/LPS38291.
9. National Alliance for Model State Drug Laws. Prescription Drug Monitoring Programs: A Brief Overview National Alliance for Model State Drug Laws (NAMSDL). Available at: ; Accessed 17.08.10. http://www.namsdl.org/documents/PMPsBriefOverview8-17-2010.pdf.
10. Alliance of States with Prescription Monitoring Programs. Status of Prescription Monitoring Programs. Available at: ; Accessed 19.07.12. http://www.pmpalliance.org/content/prescription-monitoring-frequently-asked-questions-faq.
11. National Alliance for Model State Drug Laws. Status of State Prescription Drug Monitoring Programs (PDMPs). Available at: ; Accessed 16.07.12. http://www.namsdl.org/documents/PMPProgramStatus07022012.pdf.
12. Blumenschein K., Fink J.L., Freeman P.R., Kirsh K.L., Steinke D.T., Talbert J.C. Independent Evaluation of the Impact and Effectiveness of the Kentucky all Schedule Prescription Electronic Reporting Program (KASPER) 2010, Available at:, Accessed 10.10.10. http://chfs.ky.gov/NR/rdonlyres/24493B2E-B1A1-4399-89AD-1625953BAD43/0/KASPEREvaluat:ionFinalReport10152010.pdf.
13. National Alliance for Model State Drug Laws. Compilation of State Prescription Monitoring Program Maps: State PMP Laws That Explicitly do not Require Prescribers or Dispensers to Access PMP Information. Available at. Accessed 04.08.12. http://www.namsdl.org/documents/CompilationofPMPMaps07312012.pdf.
14. Brushwood D.B. From confrontation to collaboration: collegial accountability and the expanding role of pharmacists in the management of chronic pain. J L Med Ethics 2001, 29:69-93.
15. Drug Enforcement Administration Office of Diversion Control. Pharmacist's Manual: An Informational Outline of the Controlled Substances Act. Available at. Accessed 19.10.10. http://www.deadiversion.usdoj.gov/pubs/manuals/pharm2/pharm_manual.pdf.
16. Sorg M., LaBrie S., Parker W. Analysis and Evaluation of Participation by Prescribers and Dispensers in the Maine State Prescription Monitoring Program 2009, Available at:, Accessed 24.07.12. http://mcspolicycenter.umaine.edu/files/pdf/PMP%20Report%20Final%20Nov09.pdf.
17. Reifler L.M., Droz D., Bailey J.E., et al. Do prescription monitoring programs impact state trends in opioid abuse/misuse?. Pain Med 2012, 13(3):434-442.
18. Paulozzi L.J., Stier D.D. Prescription drug laws, drug overdoses, and drug sales in New York and Pennsylvania. J Public Health Policy 2010, 31(4):422-432.
19. Green T.C., Mann M.R., Bowman S.E., et al. How does use of a prescription monitoring program change medical practice?. Pain Med 2012, 13(10):1314-1323.
20. American Society of Health-System Pharmacists ASHP statement on the pharmacist's role in substance abuse prevention, education, and assistance. Am J Health Syst Pharm 2003, 60:1995-1998.
21. Koski R.R. Pharmacists' perceptions of controlled substance abuse in the rural upper Peninsula of Michigan. J Am Pharm Assoc 2006, 46:751-753.
22. Texas Department of Public Safety This Letter will Serve as Notification of Changes to and Reminders Concerning the Texas Health and Safety Code Affecting Texas Registrants 2008, Available at:, Accessed 10.06.11. http://www.txdps.state.tx.us/criminal_law_enforcement/narcotics/index.htm.
23. Idaho State Board of Pharmacy Idaho Prescription Monitoring Program 2013, Available at:, Accessed 11.05.13. http://bop.idaho.gov/about/contact.html.
24. Ohio State Board of Pharmacy Ohio Automated RxReporting System 2013, Available at:, Accessed 11.05.13. https://www.ohiopmp.gov/Portal/Default.aspx.
25. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process 1991, 50:179-211.
26. Godin G., Belanger-Gravel A., Eccles M., Grimshaw J. Healthcare professionals' intentions and behaviours: a systematic review of studies based on social cognitive theories. Implement Sci 2008, 3:36.
27. Herbert K.E., Urmie J.M., Newland B.A., Farris K.B. Prediction of pharmacist intention to provide Medicare medication therapy management services using the theory of planned behavior. Res Soc Adm Pharm 2006, 2:299-314.
28. Pradel F.G., Obeidat N.A., Tsoukleris M.G. Factors affecting pharmacists' pediatric asthma counseling. J Am Pharm Assoc 2007, 47:737-746.
29. Gavaza P., Brown C.M., Lawson K.A., Rascati K.L., Wilson J.P., Steinhardt M. Examination of pharmacists' intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior. Res Soc Adm Pharm 2011, 7:369-382.
30. Conner M., Sparks P. Theory of planned behaviour and health behaviour. Predicting Health Behaviour: Research and Practice with Social Cognition Models 2005, 170-222. Open University Press, Berkshire, England. 2nd ed. M. Conner, P. Norman (Eds.).
31. Gorsuch R.L., Ortberg J. Moral obligation and attitudes: their relation to behavioral intentions. J Pers Soc Psychol 1983, 44:1025.
32. Randall D.M., Gibson A.M. Ethical decision making in the medical profession: an application of the theory of planned behavior. J Bus Ethics 1991, 10:111-122.
33. Woods J. East Side Pharmacist Indicted on 227 Drug Counts 2010, The Columbus Dispatch, Available at:, Accessed 11.03.11. http://www.dispatch.com/live/content/local_news/stories/2010/09/23/fletcher.html.
34. WKRN-TV Nashville Police: Pharmacist Traded Drugs for Sex 2009, Available at:, Accessed 19.10.10. http://www.wkrn.com/story/10733698/police-pharmacist-traded-drugs-for-sex%3fredirected%3dtrue.
35. Ajzen I. Constructing a TPB Questionnaire: Conceptual and Methodological Considerations 2002, Available at:, Accessed 14.04.09. http://people.umass.edu/aizen/pdf/tpb.measurement.pdf.
36. Francis J.J., Eccles M.P., Johnston M., et al. Constructing Questionnaires Based on the Theory of Planned Behaviour: A Manual for Health Services Researchers 2004, Available at:, Accessed 09.08.09. http://www.rebeqi.org/ViewFile.aspx%3fitemID%3d212.
37. Dillman D.A., Smyth J.D., Christian L.M. Internet, Mail, and Mixed-Mode Surveys: the Tailored Design Method 2009, John Wiley and Sons, Inc., Hoboken, NJ. 3rd ed.
38. Ajzen I., Fishbein M. Understanding Attitudes and Predicting Social Behavior 1980, Prentice-Hall.
39. Robinson J.P., Shaver P.R., Wrightsman L.S. Criteria for scale selection and evaluation. Measures Personal Soc Psychol Attitudes 1991, 1:1-16.
40. Bewick V., Cheek L., Ball J. Statistics review 14: logistic regression. Crit Care 2005, 9:112-118.
41. Brushwood D., Kimberlin C. Media coverage of controlled substance diversion through theft or loss. J Am Pharm Assoc 2004, 44:439-444.
42. Horswell C. Harris County a Hot Spot for Potent Drug Trio: Area Leads the State in Doctors Doling Out Addictive Combo 2010, Houston Chronicle, Available at:, Accessed 15.09.10. http://www.chron.com/disp/story.mpl/metropolitan/7029413.html.
43. Smith M.Y., Graham J.A., Haddox J.D., Steffey A. RxPATROL: a web-based tool for combating pharmacy theft. J Am Pharm Assoc 2009, 49:599-603.
44. Ulbrich T.R., Dula C.A.C., Green C.G., Porter K., Bennett M.S. Factors influencing community pharmacists' enrollment in a state prescription monitoring program. J Am Pharm Assoc 2010, 50:588-594.
45. Odedina F.T., Hepler C.D., Segal R., Miller D. The pharmacists' implementation of pharmaceutical care (PIPC) model. Pharm Res 1997, 14:135-144.
46. Fass J.A., Hardigan P.C. Attitudes of Florida pharmacists toward implementing a State Prescription Drug Monitoring Program for controlled substances. J Manag Care Pharm 2011, 17:430-438.
47. Planas L.G., Kimberlin C.L., Segal R., Brushwood D.B., Hepler C.D., Schlenker B.R. A pharmacist model of perceived responsibility for drug therapy outcomes. Soc Sci Med 2005, 60:2393-2403.
48. Joranson D.E., Gilson A.M. Pharmacists' knowledge of and attitudes toward opioid pain medications in relation to federal and state policies. J Am Pharm Assoc 2001, 41:213-220.
49. National Center on Addiction and Substance Abuse at Columbia University Under the Counter: The Diversion and Abuse of Controlled Prescription Drugs in the U.S 2005, (NCASA at Columbia University Website), Available at:, Accessed 17.08.10. http://www.casacolumbia.org/absolutenm/articlefiles/380-under_the_counter_diversion.pdf.
50. Linden S. Charitable intent: a moral or social construct? A revised theory of planned behavior model. Curr Psych 2011, 30:355-374.
51. Chisholm M.A., Cobb H., Duke L., McDuffie C., Kennedy W.K. Development of an instrument to measure professionalism. Am J Pharm Educ 2006, 70:4.
52. Thompson D.F., Farmer K.C., Beall D.G., et al. Identifying perceptions of professionalism in pharmacy using a four-frame leadership model. Am J Pharm Educ 2008, 72:4.
53. Lafferty L., Hunter T.S., Marsh W.A. Knowledge, attitudes and practices of pharmacists concerning prescription drug abuse. J Psychoactive Drugs 2006, 38:229-232.
54. Barrett K., Watson A. Physician perspectives on a pilot prescription monitoring program. J Pain Palliat Care Pharmacother 2005, 19(3):5-13.
55. Dormuth C.R., Miller T.A., Huang A., Mamdani M.M., Juurlink D.N. Effect of a centralized prescription network on inappropriate prescriptions for opioid analgesics and benzodiazepines. CMAJ 2012, 184:E852-E856.